Hestia Insight Inc.

What they do

Hestia Insight provides AI-enhanced fundraising and business consulting services, including pre-raise strategy, market research, investor materials, and investor outreach. The company also offers fractional C-suite services (e.g., Chief Strategy Officer and CFO support) and maintains a focus on healthcare and biotech sectors through its wholly owned subsidiaries, Hestia Investments Inc. and HSTA Health Inc. Legacy operations in healthy vending and portable charging have been discontinued.

Revenue drivers

• AI Enhanced Fundraising Services — Core service offering; revenue is generated from fees for pre-raise strategy, market research, financial modeling, investor materials, and investor outreach. Revenue has been minimal; recent quarterly revenue was $16,000 for the three months ended May 31, 2026.
• Strategic Consulting and Advisory (Hestia Investments) — Provides strategic consulting, medical supply sales support, and capital market advisory to healthcare and biotech companies. Revenue contribution has been negligible in recent periods.
• Future Licensing and Acquisitions — Company states it is positioned for strategic acquisitions and licensing opportunities; no revenue from these activities has been reported yet.

Recent performance

For fiscal year 2025 (ended November 30, 2025), revenue dropped to $8,000 from $1.2M in fiscal 2024, and net loss was $943,444 versus net income of $642,205 in 2024. Operating cash flow has been negative in each of the last five fiscal years, including -$134,272 in 2025. As of May 31, 2026, the company had total assets of $473,594, total liabilities of $835,682, and a shareholder equity deficit of -$362,088. Cash and equivalents were $19,141.

Strategy

Management has approved a strategic transformation into an AI technology company, focusing on AI-powered consulting and fundraising tools. The board has authorized a capital raise of up to $5 million through equity or convertible debt to fund AI team expansion, R&D, and marketing. The company is discontinuing legacy operations (healthy vending and portable charging) to concentrate resources on AI product development. It also intends to pursue strategic acquisitions, licensing, joint ventures, and direct investments.

Risks

• Limited operating history and revenue — The company has minimal revenue and a history of losses, making it difficult to forecast future performance.
• Negative equity and cash constraints — As of May 31, 2026, shareholder equity was -$362,088 and cash was only $19,141, indicating a high reliance on external funding.
• Execution risk in AI transformation — The shift to AI services is new and unproven, and management may fail to achieve rapid execution or profitability.
• Dependence on capital raise — The business requires substantial capital; if the $5 million raise is not completed, operations could be materially affected.

Outlook

Management expects the AI transformation to position the company for growth in AI-based business advisory services. The company plans to expand its AI product offerings into healthcare, fintech, and legal tech sectors. The capital raise is intended to support the AI team expansion and R&D initiatives, but no specific revenue guidance was provided.